Literature DB >> 34356333

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension.

Aranzazu Santiago-Hernandez1, Marta Martin-Lorenzo1, Ariadna Martin-Blazquez1, Gema Ruiz-Hurtado2,3, Maria G Barderas4, Julian Segura5, Luis M Ruilope2,3,6, Gloria Alvarez-Llamas1,7.   

Abstract

Moderately increased albuminuria, defined by an albumin to creatinine ratio (ACR) > 30 mg/g, is an indicator of subclinical organ damage associated with a higher risk of cardiovascular and renal disease. Normoalbuminuric subjects are considered at no cardiorenal risk in clinical practice, and molecular changes underlying early development are unclear. To decipher subjacent mechanisms, we stratified the normoalbuminuria condition. A total of 37 hypertensive patients under chronic renin-angiotensin system (RAS) suppression with ACR values in the normoalbuminuria range were included and classified as control (C) (ACR < 10 mg/g) and high-normal (HN) (ACR = 10-30 mg/g). Target metabolomic analysis was carried out by liquid chromatography and mass spectrometry to investigate the role of the cardiorenal risk urinary metabolites previously identified. Besides this, urinary free fatty acids (FFAs), fatty acid binding protein 1 (FABP1) and nephrin were analyzed by colorimetric and ELISA assays. A Mann-Whitney test was applied, ROC curves were calculated and Spearman correlation analysis was carried out. Nine metabolites showed significantly altered abundance in HN versus C, and urinary FFAs and FABP1 increased in HN group, pointing to dysregulation in the tricarboxylic acid cycle (TCA) cycle and fatty acids β-oxidation. We showed here how cardiorenal metabolites associate with albuminuria, already in the normoalbuminuric range, evidencing early renal damage at a tubular level and suggesting increased β-oxidation to potentially counteract fatty acids overload in the HN range.

Entities:  

Keywords:  Hypertension; albuminuria; cardiovascular risk; chronic kidney disease; free fatty acids; high-normal; metabolomics; normoalbuminuria; tricarboxylic acid cycle; β-oxidation

Year:  2021        PMID: 34356333     DOI: 10.3390/antiox10071100

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  2 in total

1.  Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease.

Authors:  Gloria Alvarez-Llamas; Aranzazu Santiago-Hernandez; Luis M Ruilope
Journal:  Clin Kidney J       Date:  2022-01-12

2.  An Effective Sodium-Dependent Glucose Transporter 2 Inhibition, Canagliflozin, Prevents Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.

Authors:  Lili He; Sai Ma; Qingjuan Zuo; Guorui Zhang; Zhongli Wang; Tingting Zhang; Jianlong Zhai; Yifang Guo
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.